MANE — Veradermics, Incorporated Share News
0.000.00%
Last trade - 00:00Brief: Veradermics Reports Fourth Quarter And Full Year 2025 Financial Results
Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO (updated)
Brief: Veradermics Completes Enrollment In Second Pivotal Phase 3 Clinical Trial Of Vdphl01 For Male Pattern Hair Loss
Veradermics soars in NYSE debut after upsized $256.3 million IPO
Advisory: Stray alert from NYSE tagged to multiple companies withdrawn
Brief: Veradermics Says It Prices Of Upsized Initial Public Offering At $17 Per Share